UroGen Pharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsUroGen Pharma

UroGen Pharma(URGN)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Jelmyto	Mitomycin	2020-04-15	2026-2031	Colorectal neoplasms , Pancreatic neoplasms , Stomach neoplasms , Urinary bladder neoplasms , Adenocarcinoma

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

urinary bladder neoplasms

,

invasive hydatidiform mole

,

rectal neoplasms

,

esophageal neoplasms

,

biliary tract neoplasms

,

,

gallbladder neoplasms

,

head and neck neoplasms

,

gastrointestinal neoplasms

,

,

bile duct neoplasms

,

unknown primary neoplasms

,

pleural effusion

,

cholangiocarcinoma

,

ampulla of vater cancer

,

nasopharyngeal neoplasms

,

mullerian mixed tumor

,

prostatic neoplasms

,

,

ovarian neoplasms

,

fallopian tube neoplasms

,

salivary gland neoplasms

,

germ cell and embryonal neoplasms

,

testicular neoplasms

,

pancreatic ductal carcinoma

,

colonic neoplasms

,

pancreatic neoplasms

,

breast neoplasms

,

colorectal neoplasms

,

,

non-small-cell lung carcinoma

,

stomach neoplasms

,

neoplasm metastasis

,

liver neoplasms

,

hepatocellular carcinoma

,

,

triple negative breast neoplasms

,

squamous cell neoplasms

,

urinary bladder neoplasms

,

lobular carcinoma

,

ductal carcinoma breast

,

diffuse intrinsic pontine glioma

,

urologic neoplasms

,

,

non-muscle invasive bladder neoplasms

,

uterine cervical neoplasms

,

urinary bladder neoplasms

,

,

non-small-cell lung carcinoma

,

pancreatic ductal carcinoma

,

hemangiosarcoma

,

prostatic neoplasms

,

pancreatic neoplasms

,

squamous cell carcinoma of head and neck

,

non-hodgkin lymphoma

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

burkitt lymphoma

complex regional pain syndromes

,

,

,

,

,

,

stress urinary incontinence

,

,

prostatic hyperplasia

,

,

magnetic resonance imaging

,

,

,

hypertrophic cicatrix

,

,

major depressive disorder

,

carpal tunnel syndrome

,

premature ejaculation

,

,

rectal neoplasms

,

low anterior resection syndrome

,

,

penile induration

,

thoracic outlet syndrome

,

postherpetic neuralgia

,

motor neuron disease

,

,

dystonic disorders

,

myofascial pain syndromes

,

,

,

,

,

temporomandibular joint disorders

,

,

,

somatoform disorders

,

essential tremor

,

,

systemic scleroderma

,

raynaud disease

,

diffuse scleroderma

,

urinary bladder diseases

,

multiple sclerosis

,

breast neoplasms

,

,

postoperative pain

,

breast diseases

,

hereditary breast and ovarian cancer syndrome

,

,

,

,

patellofemoral pain syndrome

,

,

muscle spasticity

,

overactive urinary bladder

,

urinary incontinence

,

migraine disorders

,

,

,

,

,

,

,

parkinson disease

,

,

neurogenic urinary bladder

,

,

,

healthy volunteers/patients

,

,

,

interstitial cystitis

,

drug-related side effects and adverse reactions

,

graves ophthalmopathy

,

,

,

spinal cord injuries

,

developmental disabilities

,

postoperative nausea and vomiting

,

bariatric surgery

,

,

,

traumatic brain injuries

,

herpes labialis

,

,

diabetes mellitus

,

,

,

,

abnormal reflex

,

muscle strength

,

clostridium botulinum type a

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use